Do these 3 things before closing this tab:
1Scan for outdated or missing drivers - takes under a minute2Clear out junk files and repair common Windows errors3Fix the driver behind crashes, sound loss and screen glitchesA genetically edited roundworm helped Rutgers researchers test how a human disease-associated genetic clue might affect polycystin proteins. In the worm, the altered protein failed to reach its usual location in cilia and male mating behavior was impaired. The experiment offers a way to study selected gene changes; it does not show that the same effects occur in human kidneys or point to a treatment.
What did the worm study find about polycystic kidney disease?
The study examined a change in polycystin-2, one of two proteins whose genes are involved in most cases of autosomal dominant polycystic kidney disease (ADPKD). ADPKD is an inherited condition in which fluid-filled sacs grow in the kidneys and may eventually lead to kidney failure. The proteins polycystin-1 and polycystin-2 work together, and the experiment focused on how an altered version of polycystin-2 behaved in a worm model.
As an Amazon Associate I earn from qualifying purchases.
In the paper, Juan Wang and colleagues describe a Caenorhabditis elegans model for examining conserved ADPKD-associated variants. The study was published in Genetics in 2026 (DOI: 10.1093/genetics/iyag182). Rutgers announced the findings on September 21, 2026. Rutgers’ summary of the study and a Medical Xpress report describe the work.
Why use a worm to study a kidney-disease gene?
Roundworms do not have kidneys, so this was not an attempt to recreate ADPKD as an organ disease. The value of the model is that worms have corresponding polycystin proteins, which function in cilia—small projections from cells that help them sense their surroundings. In male worms, polycystin-related sensory functions can also be assessed through mating behavior.
#1 Best Overall
- CKD, DIALYSIS, KIDNEY DISEASE & STONES – KNOW WHAT TO EAT: Diagnosed with kidney disease but left with no food guidance? This 3-chart laminated set answers the question every kidney patient has. The Kidney Friendly Food List covers 400+ foods — Vegetables, Fruits, Meat, Seafood, Nuts, Seeds & Grains — with Potassium (mg), Phosphorus, and Protein (g) per serving, plus a clear Safe vs. Avoid breakdown. Stop guessing. Start eating with confidence.
- COMPLETE OXALATE LEVEL GUIDE — ONLY ON THIS KIDNEY CHART: The Kidney Friendly Food List chart is the only kidney reference chart that tracks Hyperoxaluria risk with color-coded Oxalate Levels per serving: LOW (300mg). Critical for kidney stone prevention, CKD stage 3–4 management, and renal diet compliance.
- 28 KIDNEY-SAFE RECIPES + MEAL PLAN — YOUR RENAL DIET COOKBOOK ALTERNATIVE: Skip the 300-page renal diet cookbook. The Kidney Friendly Recipes chart delivers 28 doctor-aligned recipes — Breakfast, Lunch, Dinner & Snacks — all low-sodium, low-potassium, low-phosphorus, ready in under 30 minutes. Pair with the Kidney Friendly Meal Plan chart to build a full weekly renal diet without the overwhelm.
- LAMINATED & BUILT TO LAST, WATERPROOF, GLARE-RESISTANT: These are not flimsy paper printouts. All 3 charts are laminated for durability — waterproof, glare-resistant, and resilient enough to hang on your fridge, kitchen wall, or bring grocery shopping for years of daily use. High-resolution print ensures every food name, potassium value, and oxalate level is clearly readable at arm's length. Wipe clean with a damp cloth after kitchen spills.
- MEANINGFUL HEALTH GIFT FOR KIDNEY DISEASE PATIENTS: The most practical gift for anyone newly diagnosed with CKD, starting dialysis, managing hypertension, or following a low-oxalate diet for kidney stone prevention. Thoughtfully packaged, immediately helpful from Day 1. We stand behind every chart — if you're not completely satisfied, contact us for a hassle-free replacement or refund.
Using CRISPR, the team changed one amino-acid building block in worm polycystin-2 to model the corresponding human genetic clue. The approach lets researchers examine protein location and function in a living organism, while keeping the conclusion limited to the features the worm can model.
What changed in the mutant worms?
The altered polycystin-2 was present at about 15% of the normal amount in the main part of nerve cells and was not detectable in cilia. The amount of its partner, polycystin-1, also fell; it too was absent from cilia. These observations indicate a problem with protein abundance and localization in the tested worm cells.
The researchers also tested male mating behavior. After contacting a partner, 20% of males carrying the mutation initiated the expected response, compared with all normal males tested. Rutgers reports that the team tested 60 males in each group. These figures describe the study’s worm assays; they are not estimates of human disease risk, frequency, or severity.
The Tool Desk
Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →What happened when worms had one healthy and one altered copy?
In worms carrying both a healthy and an altered copy, the healthy polycystin-2 reached cilia while the mutant protein did not. The animals performed normally in the measured mating tests. The mutant protein did not displace the healthy protein from its location or prevent it from functioning normally in this experiment.
This result suggests that one healthy copy was sufficient for the measured function in this worm model. It does not establish how the corresponding human genetic change behaves in kidney cells.
What does the result mean for people with ADPKD?
The study does not show that the human genetic change causes the same protein-localization problem in kidney cells, nor does it establish a clinical diagnosis or predict a person’s course of disease. Rutgers says the human-cell effects need further study. The experiment also did not test a treatment.
Rank #4
Its potential value is methodological: testing selected genetic changes in a tractable model may help researchers understand how they affect conserved protein functions and, eventually, assist interpretation of uncertain genetic findings. It cannot by itself settle what a particular finding means for an individual patient.
Who conducted and funded the research?
Lead author Juan Wang is an associate research professor in Rutgers’ Department of Genetics. The work was conducted in the laboratory of Maureen Barr, a Rutgers Distinguished Professor of Genetics. Rutgers also names Carlos Nava Cruz, Inna Nikonorova, Jonathan Walsh, and Elizabeth desRanleau among the researchers. The university reports funding from the National Institutes of Health and the Polycystic Kidney Disease Foundation.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
